Reuters logo
BRIEF-Sartorius Stedim Biotech 2017 first-half figures
July 21, 2017 / 5:15 AM / 4 months ago

BRIEF-Sartorius Stedim Biotech 2017 first-half figures

July 21 (Reuters) - SARTORIUS STEDIM BIOTECH SA:

* SARTORIUS STEDIM BIOTECH S.A.: 2017 FIRST-HALF FIGURES

* H1 SALES EUR 546.7 MILLION VERSUS EUR 508.8 MILLION YEAR AGO

* H1 EBITDA EUR 2) 147.4 MILLION VERSUS EUR 136.4 MILLION YEAR AGO

* H1 NET PROFIT EUR 89.7 MILLION VERSUS EUR 83.5 MILLION YEAR AGO

* SSB CONTINUES TO PROJECT CAPITAL EXPENDITURES OF AROUND 10% TO 13% OF SALES IN CURRENT YEAR.

* CONFIRMED ITS FULL-YEAR FORECAST FOR 2017

* PROJECTS SALES REVENUE TO INCREASE BY ABOUT 8% TO 12%

* PROJECTS UNDERLYING EBITDA MARGIN TO RISE BY APPROX. 0.5 PERCENTAGE POINTS OVER PRIOR-YEAR FIGURE OF 27.5%

* BOTH FORECASTS GIVEN IN CONSTANT CURRENCIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below